Back to Search
ILIA BUHTOIAROV, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1619240629IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
35.126118(OH)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
OTHER
Class of 1998
Research & Publications (12)
Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma.
PMID 19638464·Clin Cancer Res·2009
7-preclinical
Tumoricidal effects of activated macrophages in a mouse model of chronic lymphocytic leukemia.
PMID 19454672·J Immunol·2009
7-preclinical
Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules.
PMID 19201847·J Immunol·2009
7-preclinical
Intratumoral immunocytokine treatment results in enhanced antitumor effects.
PMID 18438664·Cancer Immunol Immunother·2008
7-preclinical
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors.
PMID 18214476·Cancer Immunol Immunother·2008
7-preclinical
Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.
PMID 17163960·Immunology·2007
7-preclinical
Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha.
PMID 16771862·Immunology·2006
7-preclinical
In vivo CD40 ligation can induce T-cell-independent antitumor effects that involve macrophages.
PMID 16565324·J Leukoc Biol·2006
7-preclinical
Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects.
PMID 16365423·J Immunol·2006
7-preclinical
CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro.
PMID 15879094·J Immunol·2005
7-preclinical
Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy.
PMID 15269160·Clin Cancer Res·2004
7-preclinical
Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease.
PMID 12840055·J Clin Invest·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE # R3-118
CLEVELAND, OH 44195 - Phone
- (216) 444-3736
Quick Facts
- NPI
- 1619240629
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 12
Are you this provider?
Claim Your Profile